Vancomycin Dosing Recommendations
For serious infections like bacteremia, endocarditis, osteomyelitis, meningitis, and hospital-acquired pneumonia, administer 15-20 mg/kg (based on actual body weight) every 8-12 hours targeting trough concentrations of 15-20 mg/L, with doses exceeding 1 gram infused over 1.5-2 hours to minimize infusion-related reactions. 1
Standard Dosing for Normal Renal Function
Adults
- Loading dose: 25-30 mg/kg (actual body weight) for serious infections to rapidly achieve therapeutic levels 2
- Maintenance dose: 15-20 mg/kg every 8-12 hours 1
- Standard FDA dosing: 2 g daily divided as either 500 mg every 6 hours or 1 g every 12 hours 2
Critical point: The FDA label's standard 2 g/day dosing is insufficient for serious infections. The IDSA/ASHP/SIDP guidelines explicitly state that 15-20 mg/kg dosing is required to achieve target troughs of 15-20 mg/L when MIC ≤1 mg/L 1. Currently available nomograms were not designed to achieve these higher targets and should not be relied upon 1.
Infusion Guidelines
- Concentration: Maximum 5 mg/mL (up to 10 mg/mL only if fluid restriction required, though this increases infusion reaction risk) 2
- Rate: ≤10 mg/min 2
- Duration: Minimum 60 minutes for standard doses; extend to 1.5-2 hours when individual doses exceed 1 gram 1, 2
Renal Function Adjustments
Patients with Impaired Renal Function
The initial loading dose should always be at least 15 mg/kg regardless of renal function to achieve prompt therapeutic concentrations 2. This is a common pitfall—clinicians often reduce the loading dose in renal impairment, but this delays therapeutic levels.
For maintenance dosing, use the following approach:
Dosing formula: Daily vancomycin dose (mg) ≈ 15 × creatinine clearance (mL/min) 2
| Creatinine Clearance (mL/min) | Vancomycin Dose (mg/24h) |
|---|---|
| 100 | 1,545 |
| 90 | 1,390 |
| 80 | 1,235 |
| 70 | 1,080 |
| 60 | 925 |
| 50 | 770 |
| 40 | 620 |
| 30 | 465 |
| 20 | 310 |
| 10 | 155 |
Anuria/Severe Renal Impairment
- Loading dose: 15 mg/kg 2
- Maintenance: 1.9 mg/kg per 24 hours, or more practically 250-1,000 mg every several days 2
- Anuria: 1,000 mg every 7-10 days 2
Calculating Creatinine Clearance
When measured CrCl unavailable, use Cockcroft-Gault:
- Men: [Weight (kg) × (140 - age)] ÷ [72 × serum creatinine (mg/dL)]
- Women: 0.85 × above value 2
Important caveat: Recent evidence suggests CKD-EPI equation may be superior to Cockcroft-Gault for vancomycin dosing in critically ill patients, showing better correlation with vancomycin clearance 3. Consider using CKD-EPI when available, particularly in ICU settings.
Special Populations
Pediatric Patients
- Standard: 10 mg/kg every 6 hours, infused over ≥60 minutes 2
- Close monitoring of serum concentrations warranted 2
Neonates
- Initial dose: 15 mg/kg 2
- First week of life: 10 mg/kg every 12 hours 2
- After first week to 1 month: 10 mg/kg every 8 hours 2
- Premature infants: Longer intervals required due to decreased clearance with lower postconceptional age 2
Obese Patients
Use actual body weight for dosing calculations 1. Recent pharmacokinetic modeling demonstrates that vancomycin clearance increases linearly with total body weight, and both loading and maintenance doses require adjustment for total body weight to achieve AUC targets of 400-600 mg·h/L 4.
Critically Ill Patients
- ICU patients demonstrate 15.5% lower vancomycin clearance compared to ward patients 4
- Consider higher initial doses, particularly in trauma patients who often require dose increases (84% in one study) 3
- Adsorptive membranes (e.g., oXiris) in CRRT slightly increase vancomycin clearance 5
Elderly Patients
Greater dose reductions than expected may be necessary due to decreased renal function 2. Aging is associated with reduced vancomycin clearance independent of measured renal function 5.
Therapeutic Drug Monitoring
Target Concentrations
- Serious infections (bacteremia, endocarditis, osteomyelitis, meningitis, HAP): Trough 15-20 mg/L 1
- Standard infections: Trough 10-15 mg/L 1
- Target AUC/MIC: ≥400 (achievable with 15-20 mg/L troughs when MIC ≤1 mg/L) 1
Monitoring Schedule
- First trough: Before the fourth dose at steady state 1
- Short courses (≤5 days) or lower-intensity dosing (target trough ≤15 mg/L): Frequent monitoring not recommended 1
- High-risk patients: Monitor troughs for those receiving aggressive dosing (sustained 15-20 mg/L), concurrent nephrotoxins, or unstable renal function 1
Do not monitor peak concentrations—there is Level I evidence that peak monitoring does not reduce nephrotoxicity 1.
Key Clinical Pitfalls
Using standard 1 g Q12h dosing for serious infections: This achieves inadequate troughs for complicated S. aureus infections 1
Reducing loading dose in renal impairment: Always give full 15-20 mg/kg loading dose regardless of renal function 2
MIC ≥2 mg/L: Target AUC/MIC ≥400 is not achievable with conventional dosing in normal renal function—consider alternative therapy 1
Rapid infusion: Infusing too quickly (>10 mg/min) or at excessive concentrations increases risk of "red man syndrome" and infusion reactions 2
Relying on old nomograms: These were not designed to achieve current target troughs of 15-20 mg/L 1
Inadequate dose adjustments: Recent implementation studies show that protocol-driven dosing with weight-based loading doses and scheduled TDM reduces time to therapeutic levels from 4 to 2 measurements and decreases subtherapeutic exposures from 38% to 26% 6
Nephrotoxicity Monitoring
Define vancomycin-induced nephrotoxicity as: ≥2-3 consecutive elevated serum creatinine measurements (increase ≥0.5 mg/dL or ≥50% from baseline) after several days of therapy, without alternative explanation 1.
Monitor trough concentrations primarily in patients receiving aggressive dosing or those at high risk (concurrent nephrotoxins, unstable renal function) 1.